Total Payments
$2,299
2022 Payments
$1,044
Companies
12
Transactions
145
Medicare Patients
480
Medicare Billing
$69,912
Payment Breakdown by Category
Food & Beverage$2,159 (93.9%)
Education$140.13 (6.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,159 | 142 | 93.9% |
| Education | $140.13 | 3 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $379.75 | 22 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $367.93 | 34 | $0 (2022) |
| ITI, Inc. | $344.90 | 16 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $218.32 | 11 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $205.75 | 12 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $171.89 | 10 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $145.67 | 11 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $134.37 | 10 | $0 (2021) |
| ABBVIE INC. | $98.63 | 7 | $0 (2022) |
| Lundbeck LLC | $85.87 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,044 | 60 | ITI, Inc. ($200.49) |
| 2021 | $1,255 | 85 | Alkermes, Inc. ($243.45) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Central Nervous System | ||||||
| 11/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Neuroscience | ||||||
| 10/07/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Central Nervous System | ||||||
| 09/23/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: CNS | ||||||
| 09/15/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Neuropsychiatry | ||||||
| 09/13/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: PSYCHIATRY | ||||||
| 09/08/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Central Nervous System | ||||||
| 08/25/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Neuropsychiatry | ||||||
| 08/11/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Central Nervous System | ||||||
| 08/08/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: CNS | ||||||
| 08/04/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: PSYCHIATRY | ||||||
| 08/02/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Neuroscience | ||||||
| 07/28/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 07/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: PSYCHIATRY | ||||||
| 07/11/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: CNS | ||||||
| 07/07/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Central Nervous System | ||||||
| 07/05/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: PSYCHIATRY | ||||||
| 06/28/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 128 | 430 | $84,180 | $26,628 |
| 2022 | 2 | 110 | 271 | $48,792 | $13,774 |
| 2021 | 2 | 95 | 287 | $47,109 | $16,178 |
| 2020 | 4 | 147 | 313 | $28,841 | $13,332 |
Total Patients
480
Total Services
1,301
Medicare Billing
$69,912
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 336 | $67,200 | $22,028 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 78 | $11,700 | $3,039 | 26.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $5,280 | $1,561 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 126 | $24,830 | $8,036 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 145 | $23,962 | $5,738 | 23.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 141 | $26,085 | $9,637 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 146 | $21,024 | $6,541 | 31.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 127 | $12,726 | $5,964 | 46.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 157 | $12,356 | $5,488 | 44.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 15 | 15 | $2,700 | $1,229 | 45.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 14 | 14 | $1,059 | $651.64 | 61.6% |
About Carol Counts Robinson, PHD, PMHNP-BC,ANP-BC
Carol Counts Robinson, PHD, PMHNP-BC,ANP-BC is a Clinical healthcare provider based in Framingham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2010. The National Provider Identifier (NPI) number assigned to this provider is 1558679050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carol Counts Robinson, PHD, PMHNP-BC,ANP-BC has received a total of $2,299 in payments from pharmaceutical and medical device companies, with $1,044 received in 2022. These payments were reported across 145 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,159).
As a Medicare-enrolled provider, Counts Robinson has provided services to 480 Medicare beneficiaries, totaling 1,301 services with total Medicare billing of $69,912. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical
- Other Specialties Adult Health, Psychiatric/Mental Health
- Location Framingham, MA
- Active Since 09/17/2010
- Last Updated 09/27/2022
- Taxonomy Code 103TC0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558679050
Products in Payments
- CAPLYTA (Drug) $344.90
- ARISTADA (Drug) $331.10
- AUSTEDO (Drug) $281.44
- INVEGA SUSTENNA (Drug) $205.75
- REXULTI (Drug) $196.22
- INGREZZA (Drug) $171.89
- TRINTELLIX (Drug) $145.67
- LATUDA (Drug) $134.37
- VRAYLAR (Drug) $98.63
- ABILIFY MAINTENA (Drug) $79.58
- Nuedexta (Drug) $73.43
- HETLIOZ (Drug) $60.63
- LYBALVI (Drug) $33.72
- BRINTELLIX (Drug) $28.39
- VIVITROL (Drug) $14.93
- NUEDEXTA (Drug) $11.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.